Evidence map›Paper›PMID 28963851›Full record

ArticleFEBS letters2017

Measurement of

Kumar Pichumani, Tomoyuki Mashimo, Vamsidhara Vemireddy, Omkar B Ijare, Bruce E Mickey, Craig R Malloy, Isaac Marin-Valencia, David S Baskin, Robert M Bachoo, Elizabeth A Maher

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in FEBS letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Magnetic resonance spectroscopy for the study of cns malignancies.Progress in nuclear magnetic resonance spectroscopy · 2021
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Kumar PichumaniDepartment of Neurosurgery and Houston Methodist Research Institute, Kenneth R. Peak Brain and Pituitary Tumor Treatment Center at Houston Methodist Hospital, Houston, TX, USA.
Tomoyuki MashimoSimmons Cancer Center, Dallas, TX, USA.
Vamsidhara VemireddyAnnette G. Strauss Center for Neuro-Oncology, Dallas, TX, USA.
Omkar B IjareDepartment of Neurosurgery and Houston Methodist Research Institute, Kenneth R. Peak Brain and Pituitary Tumor Treatment Center at Houston Methodist Hospital, Houston, TX, USA.
Bruce E MickeyDepartment of Neurological Surgery, UT Southwestern Medical Center, Dallas, TX, USA.
Craig R MalloyDepartment of Internal Medicine, UT Southwestern Medical Center, Dallas, TX, USA.
Isaac Marin-ValenciaPediatric Brain Disease Laboratory, The Rockefeller University, New York, NY, USA.
David S BaskinDepartment of Neurosurgery and Houston Methodist Research Institute, Kenneth R. Peak Brain and Pituitary Tumor Treatment Center at Houston Methodist Hospital, Houston, TX, USA.
Robert M BachooSimmons Cancer Center, Dallas, TX, USA.
Elizabeth A MaherSimmons Cancer Center, Dallas, TX, USA.
Houston Methodist · USThe University of Texas Southwestern Medical Center · USCenter for Neuro-Oncology · USMethodist Hospital · USRockefeller University · USSouthwestern Medical CenterTexas Oncology · USVA North Texas Health Care System · US

Funding

TR&D 3: Imaging Carbohydrate MetabolismP41EB015908 · NIBIB · UT SOUTHWESTERN MEDICAL CENTER · PI MALLOY, CRAIG R · 2012 to 2021
$10.9M
Understanding the role of IDH in malignant gliomasR01CA154843 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MAHER, ELIZABETH A · 2012 to 2022
$3.5M
NCI NIH HHS R01 CA154843NIBIB NIH HHS P41 EB015908
6 · The paper itself

Abstract

Malignant brain tumors are known to utilize acetate as an alternate carbon source in the citric acid cycle for their bioenergetics.

Indexed as

AcetatesBrain NeoplasmsCarbon IsotopesFemaleGlutamic AcidGlutamineHumansMaleAcetatesCarbon IsotopesGlutamic AcidGlutamine[1,2-13C]acetate13C isotopomeracetyl-CoAglutamate and glutamine synthesisperipheral metabolism

Identifiers

PMID28963851
PMCPMC5763554
OpenAlexW2759279927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.